SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH H impact

Chemomab Therapeutics Announces Third Quarter 2026 Financial Results and Provides Corporate Update

Proposed merger with Scipher Medicine with plans to assess nebokitug in a Phase 2 precision medicine

CMMB

Related stories